Workflow
Cannabis
icon
Search documents
Wall Street Lunch: Ferrari Revs Up Elettrica (undefined:RACE)
Seeking Alpha· 2025-10-09 18:42
Massimo Merlini/iStock Unreleased via Getty Images Listen below or on the go on Apple Podcasts and Spotify Ferrari’s first EV will have 1,000 horsepower and unique engine sound. (0:15) Silver tops $50. (2:06) Hollywood vs. AI. (2:50) This is an abridged transcript of the podcast: Our top story so far, Ferrari (NYSE:RACE) unveiled some details about its first electric vehicle, which has a placeholder name of Elettrica. The EV will have in-house-developed electric motors with 1,000 horsepower, going fr ...
X @Bloomberg
Bloomberg· 2025-10-09 17:36
After a years-long slump the cannabis industry is ready for a second look, according to a Canaccord Genuity analyst who kicked off coverage by rating four out of five cannabis stocks as buys https://t.co/5S9a1SFqSF ...
Analyst talks AI trade bubble, Intel's new Panther Lake chip, Fed divided on economic risks
Youtube· 2025-10-09 17:11
Welcome to Market Catalyst. I'm Julie Heyman. We are 30 minutes into the US trading day.Here's what we're watching this hour. First off, US stocks close and fresh record highs, but is the AI trade a bubble. We'll discuss.Plus, Delta forecast strong demand. We'll have more on the results and how the shutdown is affecting airlines. and Federal Reserve officials signal more rate cuts.But how could inflation change its path. All that and more on Market Catalyst. Let's take a look at the major averages.Right now ...
Q3 Earnings Season Begins On Positive Note
ZACKS· 2025-10-09 16:20
Market Overview - Pre-market earnings are flat-to-down, with the Dow down 16 points, S&P 500 up 1 point, and Nasdaq down 4 points, while the small-cap Russell 2000 is down 2 points [1] Employment Data - Weekly Jobless Claims numbers are absent for the second consecutive week; the last reported figure showed a drop from 264K to 218K, a decrease of 46K [2] - Continuing Claims have stabilized around 1.93 million, below the 13-week range of 1.94-1.975 million [2] Retail Sector Insights - CNBC's NRF Retail Monitor report for September indicates a decline in retail and restaurant sales by 0.7%, following a 0.5% increase in August; core retail sales also fell by 0.5% from a previous increase of 0.3% [3][4] - The year-over-year growth for retail sales has decreased to 5.4% for headline and 5.7% for core, down from 6.8% and 6.7% respectively a month ago, indicating a healthy spending level despite the recent declines [4] Q3 Earnings Reports - Delta Air Lines reported Q3 earnings of $1.71 per share, exceeding the $1.52 analysts' expectations, with revenues of $16.67 billion, surpassing the Zacks consensus by 5.61% and up from $15.68 billion year-over-year [5][6] - Delta has raised its Q4 earnings guidance to a range of $1.60-1.90 per share, leading to an 8% increase in shares during pre-market trading [6] - PepsiCo reported Q3 earnings of $2.29 per share, slightly above consensus estimates, with revenues of $23.94 billion, outperforming expectations by 0.25%; however, shares are down 8% year-to-date [7] - Tilray reported fiscal Q1 earnings of $0.00 per share, exceeding expectations of -$0.03, with revenues of $210 million, up from anticipated $206.8 million; non-medical cannabis revenues increased by 12% year-over-year, resulting in an 18% rise in shares during pre-market activity [8]
Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt
Benzinga· 2025-10-09 14:43
Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings.The company reported a break-even versus a consensus loss of 2 cents per share. It reported adjusted net income of $3.9 million in the first quarter compared to adjusted net loss of $(6.1) million.Adjusted EBITDA increased 9% year over year to $10.2 million in the first quarter, compared to $9.3 million.Net revenue increased 5% to $209.5 million in the first quar ...
Tilray Brands stock surges as cannabis company posts Q1 profit
Proactiveinvestors NA· 2025-10-09 14:16
About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...
Tilray(TLRY) - 2026 Q1 - Earnings Call Transcript
2025-10-09 14:00
Financial Data and Key Metrics Changes - The company reported record first-quarter net revenue of $210 million, a 5% increase year over year, driven by increased cannabis sales in Canada and international markets [31][36] - Net income for the quarter was $1.5 million, compared to a net loss of $34.7 million in the prior year period, indicating a significant turnaround in profitability [35][36] - Adjusted EBITDA for the quarter improved to $10.2 million from $9.3 million last year, reflecting operational efficiency [36] Business Line Data and Key Metrics Changes - Cannabis revenue increased by 5% year over year to $64.5 million, supported by a 12% growth in adult use gross revenue and a 10% growth in international cannabis [31][36] - Beverage revenue reached $55.7 million, impacted by SKU rationalization but supported by new product contributions [32][36] - Wellness revenue grew by 3% year over year to CAD 15.2 million, driven by innovations in health-focused products [32][36] Market Data and Key Metrics Changes - The Canadian cannabis business reported revenue up 4% year over year to $51 million, reinforcing its position as the largest legal cannabis company in Canada by revenue [12][36] - International cannabis revenue grew by 10% year over year to $13.4 million, despite permit challenges in Portugal [14][36] - The distribution segment's revenue increased by 9% year over year to CAD 74 million, primarily due to a stronger euro [32][36] Company Strategy and Development Direction - The company aims to leverage its global platform to drive innovation in cannabis, beverage, and wellness sectors, focusing on sustainable growth and operational efficiency [5][7] - The strategic focus includes optimizing the craft beer SKU portfolio under Project Four Twenty, which has already realized $25 million in annual savings [20][21] - The company is well-positioned to capture growth opportunities in the U.S. medical cannabis market, anticipating a potential market share of 3% to 5% in a $10 billion market [11][36] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism regarding the evolving regulatory landscape for cannabis, particularly in the U.S. and Europe, which could enhance patient access and market opportunities [10][11] - The company is confident in its ability to adapt to regulatory changes and is committed to continuous innovation and portfolio expansion [28][36] - Management acknowledged the challenges faced in the beverage segment but emphasized the long-term potential for growth and profitability [20][36] Other Important Information - The company reduced its outstanding debt by $7.7 million during the quarter, bringing its net debt to $3.9 million, which enhances financial flexibility for strategic opportunities [36][37] - The company has built a diversified global platform with over 40 unique brands in more than 20 countries, positioning itself as a leader in the cannabis, beverage, and wellness markets [8][9] Q&A Session Summary Question: International growth opportunities and permit delays - Management noted progress in obtaining permits in Portugal and expressed optimism about increasing production capacity in both Portugal and Germany [41][43][44] Question: Rescheduling opportunities in the U.S. - Management indicated readiness to leverage existing infrastructure and explore partnerships or acquisitions to capture opportunities in the U.S. medical cannabis market [48][51] Question: Canadian adult use market dynamics - Management highlighted a 1.3% decline in overall market pricing, with their pricing up 2% and volume growth of 6.5%, indicating strong performance relative to the market [67][70] Question: Beverage segment profitability improvement plans - Management discussed ongoing efforts in SKU rationalization and integration of acquired brands to improve margins in the beverage segment [75][78] Question: Managing risks in Portugal and Germany - Management emphasized commitment to the Portuguese market while also having contingency plans in Germany, including the ability to ship from Canada [81][84][90]
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
Globenewswire· 2025-10-09 11:00
Operational Efficiencies and Focus on Profitability Drove Net Income of $1.5 Million, Adjusted EBITDA Increased 9% to $10 Million and Net Cash Used in Operations Improved by $34 Million Year-Over-Year Canadian Adult-Use Cannabis Gross Revenue Increased 12%, Maintaining the #1 Position in Revenue and Expanding Market Share; International Cannabis Revenue Grew 10% Year-Over-Year Balance Sheet Strengthened to $265 Million in Cash; Net Debt Reduced to $4 Million Reiterates Fiscal Year 2026 Adjusted EBITDA Outlo ...
Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep
Businesswire· 2025-10-09 10:00
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company†or "Organigram†), Canada's #1 cannabis company by market share, is pleased to announce the launch of happly, its third U.S. hemp-derived delta-9 brand, created specifically for the growing segment of consumers seeking 'mindful recreation' with THC products. The launch of happly follows the Company's entry into the growing U.S. hemp-derived THC market with its lineup of Collective Project sparkling juices a. ...
Tilray Brands (TLRY) Climbs 8% Ahead of Cannabis, CBD Policy Decision
Yahoo Finance· 2025-10-08 17:24
We recently published 10 Hot Stocks Sparking Buying Frenzy. Tilray Brands Inc. (NASDAQ:TLRY) is one of the best performers on Tuesday. Tilray Brands Inc. (NASDAQ:TLRY) grew its share prices by 8.23 percent on Tuesday to finish at $1.71 apiece as investors repositioned portfolios ahead of an expected decision from President Donald Trump on the legalization of cannabis and Cannabidiol (CBD) products. With a positive decision expected in the coming weeks, investors are already pouring funds into cannabis pr ...